$8.980
+0.485 (+5.40%)收盘时
ETRA 同业对比
In the context of the broader market, ETRA competes directly with industry leaders such as ACRS and DBVT. With a market capitalization of $548.68M, it holds a significant position in the sector. When comparing efficiency, ETRA's gross margin of N/A stands against ACRS's 10.80% and DBVT's 100.00%. Such benchmarking helps identify whether Electra Therapeutics, Inc. is trading at a premium or discount relative to its financial performance.
Electra Therapeutics, Inc. Common stock 财务表现
Electra Therapeutics has a price-to-book ratio of -21.688, indicating negative equity, and both its PE and forward PE ratios are 0, suggesting no earnings are currently being generated.
Financials
No data
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。